Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.69 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.51 |
| ▸ | LTB4R | Q15722 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2835656 | 1.00 | MAPT (0.69) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL25575670 | 1.00 | MAPT (0.69) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL9860436 | 1.00 | MAPT (0.69) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL2197174 | 0.98 | MAPT (0.66) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| Iocanlidic Acid SCHEMBL27870026 | 0.93 | MAPT (0.61) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL452845 | 0.92 | SMN1; SMN2 (0.67) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL29256339 | 0.91 | MAPT (0.58) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL6015502 | 0.90 | MAPT (0.57) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL3814880 | 0.90 | MAPT (0.83) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL9671779 | 0.90 | MAPT (0.83) | MAPTRXFP1HDAC3MAPK1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118606615-B | Method, system, equipment and storage medium for acquiring automobile mass center inertia matrix | 哈尔滨工业大学 | 2025-05-30 | — | — | CN | claimed |
| CN-119661634-A | Fructus cannabis extract polypeptide with blood glucose reducing function | 清华大学深圳国际研究生院 | 2025-03-21 | — | — | CN | claimed |
| CN-118606615-A | Method, system, equipment and storage medium for acquiring automobile mass center inertia matrix | 哈尔滨工业大学 | 2024-09-06 | — | — | CN | claimed |
| WO-2024152094-A1 | METHOD FOR REDUCING THE COLOURING OF SUGAR, PROCESS FOR PRODUCING SUGAR WITH LOW COLOUR, COMPOSITION AND USE OF A CHELATING AGENT | ITALMATCH CHEMICALS SPA (IT) | 2024-07-25 | — | — | WO | claimed |
| WO-2024097388-A1 | SYSTEMS AND METHODS FOR MONITORING FATTY ACID METABOLISM | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-05-10 | — | — | WO | claimed |
| CN-115322283-B | Preparation method of anti-scaling, drag-reducing and thickening integrated fracturing emulsion | 爱森（中国）絮凝剂有限公司 | 2023-06-09 | — | — | CN | claimed |
| CN-115322283-A | Preparation method of anti-scaling, anti-drag and thickening integrated fracturing emulsion | 爱森（中国）絮凝剂有限公司 | 2022-11-11 | — | — | CN | claimed |
| EP-4011367-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19 | Dompe' Farmaceutici S.P.A. (IT) | 2022-06-15 | — | — | EP | claimed |
| EP-0153403-A4 | CHEMICAL COMPOUNDS. | MALLINCKRODT INC (US) | 1985-12-11 | — | — | EP | claimed |
| EP-0153403-A1 | CHEMICAL COMPOUNDS | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1985-09-04 | — | — | EP | claimed |
| WO-1985000753-A1 | CHEMICAL COMPOUNDS | MALLINCKRODT, INC. (US) | 1985-02-28 | — | — | WO | claimed |
| CN-119219861-B | High-temperature-resistant environment-friendly viscosity reducing agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-119143945-B | Crosslinked graft copolymers, process for their preparation and their use | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260091008-A1 | DOUBLE TARGETED CONSTRUCTS TO AFFECT TUMOR KILL | CORNELL UNIVERSITY (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4716929-A1 | MARINE DETECTION SYSTEM AND METHOD | Ørsted Wind Power A/S (DK) | 2026-04-01 | — | — | EP | disclosed |
| EP-0165630-A2 | Method of preparing a chlorinated, brominated, radiobrominated, iodinated and/or radioiodinated, aromatic or heteroaromatic compound, as well as a kit for preparing a diagnostic composition on the basis of this compound | MALLINCKRODT, INC.(a Missouri corporation) (US) | 1985-12-27 | — | — | EP | disclosed |
| EP-0153403-A4 | CHEMICAL COMPOUNDS. | MALLINCKRODT INC (US) | 1985-12-11 | — | — | EP | disclosed |
| EP-0153403-A1 | CHEMICAL COMPOUNDS | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1985-09-04 | — | — | EP | disclosed |
| US-4523033-A | USING 15-(P-(125I)-IODOPHENYL)-6-TELLURAPENTADECANOIC ACID | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1985-06-11 | — | — | US | disclosed |
| WO-1985000753-A1 | CHEMICAL COMPOUNDS | MALLINCKRODT, INC. (US) | 1985-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091008-A1 | DOUBLE TARGETED CONSTRUCTS TO AFFECT TUMOR KILL | PSMA2, CD47, KLK3 | MAPT 1718/4885RXFP1 940/4885HDAC3 2943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.